BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 1677932)

  • 1. Antineutrophil cytoplasmic autoantibodies: disease associations, molecular biology, and pathophysiology.
    Jennette JC; Charles LA; Falk RJ
    Int Rev Exp Pathol; 1991; 32():193-221. PubMed ID: 1677932
    [No Abstract]   [Full Text] [Related]  

  • 2. Autoimmunity to lysosomal enzymes: new clues to vasculitis and glomerulonephritis?
    Kallenberg CG; Tervaert JW; van der Woude FJ; Goldschmeding R; von dem Borne AE; Weening JJ
    Immunol Today; 1991 Feb; 12(2):61-4. PubMed ID: 1647776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experience on antineutrophil cytoplasm antibodies and antimyeloperoxidase antibodies in rapidly progressive glomerulonephritis.
    Rollino C; Roccatello D; Coppo R; Menegatti E; Basolo B; Giraudo G; Martina G; Piccoli G
    Contrib Nephrol; 1991; 94():101-6. PubMed ID: 1687269
    [No Abstract]   [Full Text] [Related]  

  • 4. Wegener's granulomatosis, microscopic polyarteritis and pauciimmune crescentic necrotizing glomerulonephritis, an overview.
    Ritz E; Andrassy K; Küster S; Waldherr R
    Przegl Lek; 1992; 49(1-2):6-9. PubMed ID: 1360686
    [No Abstract]   [Full Text] [Related]  

  • 5. Antineutrophil cytoplasmic autoantibodies and associated diseases: a review.
    Jennette JC; Falk RJ
    Am J Kidney Dis; 1990 Jun; 15(6):517-29. PubMed ID: 1973331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of autoantibodies against myeloid lysosomal enzymes: a useful adjunct to classification of patients with biopsy-proven necrotizing arteritis.
    Tervaert JW; Limburg PC; Elema JD; Huitema MG; Horst G; The TH; Kallenberg CG
    Am J Med; 1991 Jul; 91(1):59-66. PubMed ID: 1677531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Progress in the diagnosis of Wegener's granulomatosis].
    Zielonka TM; Chorzelski T; Droszcz W
    Pol Arch Med Wewn; 1991 Aug; 86(2):117-21. PubMed ID: 1775390
    [No Abstract]   [Full Text] [Related]  

  • 8. Transforming growth factor-beta (TGF-beta) expression and interaction with proteinase 3 (PR3) in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis.
    Csernok E; Szymkowiak CH; Mistry N; Daha MR; Gross WL; Kekow J
    Clin Exp Immunol; 1996 Jul; 105(1):104-11. PubMed ID: 8697616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical and pathogenetic aspects of kidney damage associated with neutrophilic cytoplasm antibodies].
    Mukhin NA; Kozlovskaia LV; Nasonov EL; Beketova TV; Semenkova EN; Makar'iants ML
    Vestn Ross Akad Med Nauk; 1995; (5):34-9. PubMed ID: 7626983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis.
    Falk RJ; Jennette JC
    N Engl J Med; 1988 Jun; 318(25):1651-7. PubMed ID: 2453802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [ANCA: vasculitis research on the upswing].
    Michel BA
    Z Rheumatol; 1995; 54(5):277-8. PubMed ID: 8578883
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of systemic and renal-limited vasculitic disorders with pooled human intravenous immune globulin.
    Jordan SC
    J Clin Immunol; 1995 Nov; 15(6 Suppl):76S-85S. PubMed ID: 8613496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pathogenic role of antimyeloperoxidase antibodies].
    Guilpain P; Maldini C; Guillevin L
    Rev Med Interne; 2011 Jul; 32(7):411-5. PubMed ID: 20633964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pathogenic role of antineutrophil cytoplasmic autoantibodies.
    Ewert BH; Jennette JC; Falk RJ
    Am J Kidney Dis; 1991 Aug; 18(2):188-95. PubMed ID: 1651049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pulmonary vasculitis].
    Cordier JF
    Rev Med Interne; 2002 Dec; 23 Suppl 5():547s-548s. PubMed ID: 12701246
    [No Abstract]   [Full Text] [Related]  

  • 16. Hypogalactosylation of serum IgG in patients with ANCA-associated systemic vasculitis.
    Holland M; Takada K; Okumoto T; Takahashi N; Kato K; Adu D; Ben-Smith A; Harper L; Savage CO; Jefferis R
    Clin Exp Immunol; 2002 Jul; 129(1):183-90. PubMed ID: 12100039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diverse target antigens recognized by circulating antibodies in anti-neutrophil cytoplasm antibody-associated renal vasculitides.
    Savige JA; Gallicchio M; Georgiou T; Davies DJ
    Clin Exp Immunol; 1990 Nov; 82(2):238-43. PubMed ID: 1978702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of diseases associated with antineutrophil cytoplasm autoantibodies.
    Reumaux D; Duthilleul P; Roos D
    Hum Immunol; 2004 Jan; 65(1):1-12. PubMed ID: 14700590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro.
    Falk RJ; Terrell RS; Charles LA; Jennette JC
    Proc Natl Acad Sci U S A; 1990 Jun; 87(11):4115-9. PubMed ID: 2161532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antineutrophil cytoplasm antibodies in systemic polyarteritis nodosa with and without hepatitis B virus infection and Churg-Strauss syndrome--62 patients.
    Guillevin L; Visser H; Noel LH; Pourrat J; Vernier I; Gayraud M; Oksman F; Lesavre P
    J Rheumatol; 1993 Aug; 20(8):1345-9. PubMed ID: 7901412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.